Claim Your New User Special: Get your second month free ▶ Second Month Free

Serving leading biopharmaceutical companies globally:

Colorcon
Harvard Business School
Express Scripts
Medtronic
McKesson
Boehringer Ingelheim

Last Updated: May 26, 2022

Alvogen Pine Brook Company Profile


✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for ALVOGEN PINE BROOK, and what generic and branded alternatives to ALVOGEN PINE BROOK drugs are available?

ALVOGEN PINE BROOK has three approved drugs.



Drugs and US Patents for Alvogen Pine Brook

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alvogen Pine Brook HYDROCODONE BITARTRATE hydrocodone bitartrate TABLET, EXTENDED RELEASE;ORAL 208269-003 Mar 1, 2021 AB RX No No See Plans and Pricing See Plans and Pricing
Alvogen Pine Brook HYDROCODONE BITARTRATE hydrocodone bitartrate TABLET, EXTENDED RELEASE;ORAL 208269-004 Mar 1, 2021 AB RX No No See Plans and Pricing See Plans and Pricing
Alvogen Pine Brook BOSENTAN bosentan TABLET;ORAL 206002-002 Apr 26, 2019 DISCN No No See Plans and Pricing See Plans and Pricing
Alvogen Pine Brook OSELTAMIVIR PHOSPHATE oseltamivir phosphate FOR SUSPENSION;ORAL 208823-001 Oct 31, 2017 AB RX No No See Plans and Pricing See Plans and Pricing
Alvogen Pine Brook HYDROCODONE BITARTRATE hydrocodone bitartrate TABLET, EXTENDED RELEASE;ORAL 208269-005 Mar 1, 2021 AB RX No No See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Boehringer Ingelheim
Moodys
Harvard Business School
AstraZeneca
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.